세계의 심장 폐쇄 기기 시장 : 산업 규모, 점유율, 동향, 기회, 예측 - 폐쇄 유형별(선천성 심결손폐쇄{수기별(ASD,PDA,VSD), PFO 폐쇄, LAA 폐쇄), 지역별 부문 및 경쟁(2020-2030년)

Heart Closure Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Closure Type (Congenital Heart Defect Closure{By Technique( ASD,PDA,VSD)},PFO Closure, LAA Closure) By Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,197,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,574,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,017,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 심장 폐쇄 기기 시장은 2024년에 28억 4,000만 달러로 평가되었고, 예측 기간 동안 CAGR 10.39%로 성장할 전망이며, 2030년에는 51억 4,000만 달러에 이를 것으로 예측됩니다.

심장 폐쇄 기기는 심방중격결손증(ASD), 난원공개존증(PFO), 심실중격결손증(VSD) 등의 구조적 심장 결함을 치료하기 위해 설계되었으며 개심술을 대체하는 저침습 대체 의료를 제공합니다. 심혈관 질환의 유병률 상승, 카테터를 이용한 수술의 채용 증가, 디바이스 재료나 설계의 진보, 노인 인구 증가에 의해 시장은 급속하게 확대되고 있습니다. 경 카테터적 폐쇄 기기 및 강화된 화상 기술 등의 기술 혁신은, 이러한 수기를 보다 정확하고 저침습으로 해, 채용을 한층 더 촉진하고 있습니다. 외상이 적은 치료와 환자의 전귀 개선을 요구하는 세계의 움직임은 특히 헬스케어 인프라가 발달하고 심장결함 치료에 대한 의식이 높아지고 있는 지역에서 이들 기기에 대한 수요를 지속적으로 촉진하고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모(2024년)	28억 4,000만 달러
시장 규모(2030년)	51억 4,000만 달러
CAGR(2025-2030년)	10.39%
급성장 부문	CHD 클로저
최대 시장	북미

시장 성장 촉진요인

기술 진보

주요 시장 과제

상환 문제

주요 시장 동향

경 카테터 폐쇄 기기

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 심장 폐쇄 기기 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율 및 예측
  • 폐쇄 유형별(CHD 폐쇄, PFO 폐쇄, LAA 폐쇄)
  • 기업별(2024년)
  • 지역별
• 시장 맵

제6장 북미의 심장 폐쇄 기기 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 심장 폐쇄 기기 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 심장 폐쇄 기기 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 심장 폐쇄 기기 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 심장 폐쇄 기기 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향 및 발전

• 최근 동향
• 제품 출시
• 합병 및 인수

제13장 PESTEL 분석

제14장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Gore & Associates, Inc.
• Abbott Laboratories
• AtriCure Inc.
• Lifetech Scientific
• Occlutech
• Lepu Medical Technology(Beijing) Co., Ltd.
• Heartstitch
• SMT
• Cardiac, Inc.
• Boston Scientific Corporation

제16장 전략적 제안

제17장 기업 소개 및 면책사항

AJY

영문 목차

영문목차

The Global Heart Closure Devices Market was valued at USD 2.84 billion in 2024 and is projected to reach USD 5.14 billion by 2030, growing at a CAGR of 10.39% during the forecast period. Heart closure devices are designed to treat structural heart defects such as atrial septal defects (ASDs), patent foramen ovale (PFO), and ventricular septal defects (VSD), providing a minimally invasive alternative to open-heart surgery. The market is expanding rapidly due to the rising prevalence of cardiovascular conditions, increasing adoption of catheter-based procedures, advancements in device materials and design, and the growing geriatric population. Technological innovations, such as transcatheter closure devices and enhanced imaging techniques, are making these procedures more precise and less invasive, further driving adoption. The global push for less traumatic interventions and improved patient outcomes continues to fuel demand for these devices, especially in regions with advanced healthcare infrastructure and rising awareness about heart defect treatments.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.84 Billion
Market Size 2030	USD 5.14 Billion
CAGR 2025-2030	10.39%
Fastest Growing Segment	CHD Closure
Largest Market	North America

Key Market Drivers

Technological Advancements

Technological progress has significantly contributed to the expansion of the heart closure devices market. Developments in biomaterials and engineering have led to devices that are smaller, more flexible, and easier to implant, improving patient comfort and clinical outcomes. Innovations in catheter-based techniques enable minimally invasive procedures, reducing recovery time and surgical risks. Additionally, the integration of real-time imaging technologies such as 3D imaging and intracardiac echocardiography (ICE) allows for accurate visualization and placement of closure devices. These advancements have expanded treatment options for patients with congenital or acquired heart defects and have made these procedures more accessible and safer, which has helped boost overall market growth.

Key Market Challenges

Reimbursement Issues

Inconsistent and limited reimbursement policies represent a significant challenge in the heart closure devices market. Coverage and reimbursement vary widely across countries and healthcare systems, influencing patient access and the financial viability of procedures. In regions where reimbursement is limited or unclear, patients may face high out-of-pocket costs, deterring them from undergoing treatment. Healthcare providers also encounter administrative burdens and delays in securing reimbursement, which can limit their ability to offer these procedures consistently. These factors create disparities in treatment availability and restrict the adoption of heart closure devices, particularly in lower-income or publicly funded healthcare environments.

Key Market Trends

Transcatheter Closure Devices

Transcatheter closure devices are gaining prominence as the preferred approach for treating structural heart defects. These devices are delivered through catheters, offering a highly targeted and minimally invasive method of closure that reduces surgical complications and shortens recovery time. As precision and ease-of-use improve, these devices are increasingly seen as the standard of care, particularly for conditions like PFO and ASDs. Advanced delivery systems and real-time imaging facilitate accurate deployment, contributing to better procedural outcomes. The growing demand for less invasive cardiac procedures, combined with strong clinical efficacy, is driving widespread adoption of transcatheter closure technologies and accelerating their market penetration.

Key Market Players

• Gore & Associates, Inc.
• Abbott Laboratories
• AtriCure Inc.
• Lifetech Scientific
• Occlutech
• Lepu Medical Technology (Beijing) Co., Ltd.
• Heartstitch
• SMT
• Cardiac, Inc.
• Boston Scientific Corporation

Report Scope

In this report, the Global Heart Closure Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Heart Closure Devices Market, By Closure Type:

• CHD Closure
• PFO Closure
• LAA Closure

Heart Closure Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Heart Closure Devices Market.

Available Customizations

Global Heart Closure Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Heart Closure Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
  • 5.2.2. By Company (2024)
  • 5.2.3. By Region
• 5.3. Market Map

6. North America Heart Closure Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Heart Closure Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Closure Type
  • 6.3.2. Mexico Heart Closure Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Closure Type
  • 6.3.3. Canada Heart Closure Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Closure Type

7. Europe Heart Closure Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Heart Closure Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Closure Type
  • 7.3.2. Germany Heart Closure Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Closure Type
  • 7.3.3. United Kingdom Heart Closure Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Closure Type
  • 7.3.4. Italy Heart Closure Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Closure Type
  • 7.3.5. Spain Heart Closure Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Closure Type

8. Asia-Pacific Heart Closure Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
  • 8.2.2. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Heart Closure Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Closure Type
  • 8.3.2. India Heart Closure Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Closure Type
  • 8.3.3. South Korea Heart Closure Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Closure Type
  • 8.3.4. Japan Heart Closure Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Closure Type
  • 8.3.5. Australia Heart Closure Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Closure Type

9. South America Heart Closure Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
  • 9.2.2. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Heart Closure Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Closure Type
  • 9.3.2. Argentina Heart Closure Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Closure Type
  • 9.3.3. Colombia Heart Closure Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Closure Type

10. Middle East and Africa Heart Closure Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Closure Type (CHD Closure, PFO Closure, LAA Closure)
  • 10.2.2. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Heart Closure Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Closure Type
  • 10.3.2. Saudi Arabia Heart Closure Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Closure Type
  • 10.3.3. UAE Heart Closure Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Closure Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Gore & Associates, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Abbott Laboratories
• 15.3. AtriCure Inc.
• 15.4. Lifetech Scientific
• 15.5. Occlutech
• 15.6. Lepu Medical Technology (Beijing) Co., Ltd.
• 15.7. Heartstitch
• 15.8. SMT
• 15.9. Cardiac, Inc.
• 15.10. Boston Scientific Corporation

16. Strategic Recommendations

17. About Us & Disclaimer

관련자료